STRO

Sutro Biopharma (STRO)

About Sutro Biopharma (STRO)

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Details

Daily high

$10.15

Daily low

$8.48

Price at open

$8.94

52 Week High

$21.50

52 Week Low

$5.23

Market cap

85.0M

Dividend yield

0.00%

Volume

320,291

Avg. volume

126,234

P/E ratio

-.38

Sutro Biopharma News